1. Home
  2. JYNT vs ACHV Comparison

JYNT vs ACHV Comparison

Compare JYNT & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Joint Corp.

JYNT

The Joint Corp.

HOLD

Current Price

$8.91

Market Cap

117.3M

Sector

Miscellaneous

ML Signal

HOLD

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

HOLD

Current Price

$5.26

Market Cap

172.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JYNT
ACHV
Founded
2010
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
117.3M
172.0M
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
JYNT
ACHV
Price
$8.91
$5.26
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$17.00
$14.67
AVG Volume (30 Days)
69.0K
1.3M
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
133.93
N/A
EPS
0.09
N/A
Revenue
$117,696,356.00
N/A
Revenue This Year
$12.23
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$102.44
N/A
Revenue Growth
15.49
N/A
52 Week Low
$7.50
$2.00
52 Week High
$13.47
$6.15

Technical Indicators

Market Signals
Indicator
JYNT
ACHV
Relative Strength Index (RSI) 53.40 58.87
Support Level $8.49 $4.09
Resistance Level $9.33 $5.84
Average True Range (ATR) 0.37 0.42
MACD 0.06 -0.03
Stochastic Oscillator 58.90 48.26

Price Performance

Historical Comparison
JYNT
ACHV

About JYNT The Joint Corp.

The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The company has one operating business segment; The Franchise Operations segment, which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the company's franchise license, which represents symbolic intellectual property.

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

Share on Social Networks: